Identification of race-associated metabolite biomarkers for hepatocellular carcinoma in patients with liver cirrhosis and hepatitis C virus infection
Table 4
Prediction performance in leave-one-out cross validation based on metabolites selected by LASSO or top five metabolites ranked by MSVM-RFE.